Subscribe

News
Media
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

Husna Rahim, PharmD, RPh

Articles by Husna Rahim, PharmD, RPh

Hairy cell leukemia -- Image credit: Dr_Microbe | stock.adobe.com

Emerging Role of BRAF Inhibitors in Relapsed/Refractory Hairy Cell Leukemia Treatment

ByHusna Rahim, PharmD, RPh,Sukeina Nasser, PharmD, RPh, CPh, PACS,Rezarta Lako, PharmD, BCPS,Richa Shah, PharmD, BCOP,Jessie Modlin, PharmD, BCOP,Avani Yenamandra, PharmD, BCOP,Kevin Pang, PharmD

February 24th 2025

BRAF V600E inhibitors show improved outcomes in relapsed/refractory hairy cell leukemia.

Latest Updated Articles

Trending on Pharmacy Times

Recognizing Immunizing Pharmacists in the Community

FDA, HHS Move to Accelerate Biosimilar Approvals

Accelerated Approval of Cancer Drugs: Benefit or Burden?

Denosumab Biosimilars Conexxence and Bomyntra Receive Interchangeability Designation

Pharmacists Lead the Way in Evolving CAR T-Cell and Bispecific Antibody Therapy Management

© 2025 MJH Life Sciences^®

All rights reserved.